• Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines

Vaccine-Specific GMP Production System for Human Vaccines

Product Overview

The Vaccine-Specific GMP Production System is a specialized bioreactor and supporting process system developed for the production processes of vaccines such as Pertussis, HPV, and COVID-19 vaccines. It fully meets the high compliance, high precision, and high automation requirements of human vaccine production. The system design complies with GMP and EU-related standards and is adaptable to the large-scale production of different vaccine technology routes.
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines
  • Vaccine-Specific GMP Production System for Human Vaccines

Description

Segmented Process Systems

1.Pertussis Vaccine Cultivation System

Core Design:

  The aspect ratio of the reactor is precisely controlled between 1.2 and 2.1, customized according to the growth characteristics of Bordetella pertussis cultivation; it adopts an integrated structure of surface aeration and deep aeration, supporting the automatic flow ratio adjustment of AIR and O₂ to ensure the stability of dissolved oxygen during strain cultivation.

2.HPV Vaccine Production System

Compliance Design:

  Adopts Grade A aseptic standard architecture, supporting Clean-in-Place (CIP) and Sterilization-in-Place (SIP); the tank body and material contact components are all made of AISI 316L stainless steel, with an inner surface polishing precision of 0.2μm to eliminate the risk of contamination.

Process Control:

  Integrates full-dimensional sensors such as temperature, pressure, flow, pH, DO, OD, and viable cell detection to realize real-time monitoring and automatic regulation of the production process.

Core Advantages:

It features a highly automated production process and advanced process system technology, which is suitable for the large-scale production needs of HPV vaccines.

3.COVID-19 Vaccine Multi-Technology Adaptation System

Technology Route Coverage:

  Compatible with multiple COVID-19 vaccine production processes, including inactivated vaccines, recombinant subunit vaccines, adenovirus vector vaccines, live-attenuated influenza virus vector vaccines, and nucleic acid vaccines.

Core Modules:

  Provides key process module equipment such as buffer preparation system, harvest/inactivation system, and CIP unit for production workshops, supporting the standardized implementation of the entire vaccine production process.

Core System Parameters

 Item                          

 Technical Specifications                  

 Material (Material Contact)   

 AISI 316L Stainless Steel                 

 Inner Surface Polishing Precision

 0.2μm                                  

 Compliance Standards          

 Complies with GMP and EU production regulations

 Aeration Control              

 Integrated surface + deep aeration; automatic AIR/O₂ flow ratio adjustment

 Process Monitoring Sensors    

 Temperature, Pressure, Flow, pH, DO, OD, Viable Cell Detection

 Cleaning/Sterilization Method

 Clean-in-Place (CIP), Sterilization-in-Place (SIP)

 Pertussis Reactor Aspect Ratio

 1.2-2.1                                 

System Value

The Vaccine-Specific GMP Production System focuses on process adaptability, compliance, and automation. It helps vaccine manufacturers achieve efficient, stable, and globally standardized large-scale production, and is a professional equipment solution for human vaccine production in the biopharmaceutical field.

 

Download

We use Cookie to improve your online experience. By continuing browsing this website, we assume you agree our use of Cookie.